50 years of hurdles and hope in anxiolytic drug discovery.
50 years of hurdles and hope in anxiolytic drug discovery.
复制标题
50 年来抗焦虑药物发现的障碍和希望。
DOI:
10.1038/nrd4075
复制
发表时间:
2013-09
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Anxiety disorders are the most prevalent group of psychiatric diseases, and have high personal and societal costs. The search for novel pharmacological treatments for these conditions is driven by the growing medical need to improve on the effectiveness and the side effect profile of existing drugs. A huge volume of data has been generated by anxiolytic drug discovery studies, which has led to the progression of numerous new molecules into clinical trials. However, the clinical outcome of these efforts has been disappointing, as promising results with novel agents in rodent studies have very rarely translated into effectiveness in humans. Here, we analyse the major trends from preclinical studies over the past 50 years conducted in the search for new drugs beyond those that target the prototypical anxiety-associated GABA (γ-aminobutyric acid)–benzodiazepine system, which have focused most intensively on the serotonin, neuropeptide, glutamate and endocannabinoid systems. We highlight various key issues that may have hampered progress in the field, and offer recommendations for how anxiolytic drug discovery can be more effective in the future.
登录
查看更多内容
DOI:
10.1186/2045-5380-1-9
发表时间:
2011-11-07
期刊:
Biology of mood & anxiety disorders
影响因子:
--
作者:
Belzung C;Lemoine M
通讯作者:
Lemoine M
影响因子:
2
作者:
Bergado-Acosta, Jorge R.;Sangha, Susan;Stork, Oliver
通讯作者:
Stork, Oliver
影响因子:
16.2
作者:
Bielsky, IF;Hu, SB;Young, LJ
通讯作者:
Young, LJ
影响因子:
2.9
作者:
Bhatnagar, S;Sun, LM;Dallman, MF
通讯作者:
Dallman, MF
DOI:
10.1016/s1569-7339(07)00014-8
发表时间:
2008-01-01
期刊:
HANDBOOK OF ANXIETY AND FEAR
影响因子:
--
作者:
Bortolato, Marco;Piomelli, Daniele
通讯作者:
Piomelli, Daniele